Phase I and pharmacokinetic study of a novel mitomycin C analog KW-2149.
Dirix L, Catimel G, Koier I, Provè A, Schrijvers D, Joossens E, De Bruijn E, Ardiet C, Evene E, Dumortier A, et al.
Dirix L, et al. Among authors: dumortier a.
Anticancer Drugs. 1995 Feb;6(1):53-63. doi: 10.1097/00001813-199502000-00006.
Anticancer Drugs. 1995.
PMID: 7756684
Clinical Trial.